{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:13:01Z","timestamp":1789711981575,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T00:00:00Z","timestamp":1313193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00262-011-1092-5","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T08:47:57Z","timestamp":1313138877000},"page":"63-70","source":"Crossref","is-referenced-by-count":46,"title":["CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend"],"prefix":"10.1007","volume":"61","author":[{"given":"Kevin H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah N.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,13]]},"reference":[{"issue":"1","key":"1092_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","volume":"97","author":"P Pisani","year":"2002","unstructured":"Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97(1):72\u201381. doi: 10.1002\/ijc.1571","journal-title":"Int J Cancer"},{"issue":"9","key":"1092_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2471\/BLT.06.038414","volume":"85","author":"FT Cutts","year":"2007","unstructured":"Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L (2007) Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 85(9):719\u2013726. doi: S0042-96862007000900018","journal-title":"Bull World Health Organ"},{"key":"1092_CR3","unstructured":"Cancer Facts & Figures (2010) American Cancer Society"},{"issue":"4","key":"1092_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55(4):244\u2013265","journal-title":"J Clin Pathol"},{"issue":"1","key":"1092_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12\u201319. doi: 10.1002\/(SICI)1096-9896(199909)189:1<12:AID-PATH431>3.0.CO;2-F","journal-title":"J Pathol"},{"key":"1092_CR6","unstructured":"Crum C (ed) (2004) Robbins & cotran pathologic basis of disease. 7th edn, W.B. Saunders Co., Philadelphia"},{"issue":"18","key":"1092_CR7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","volume":"327","author":"LA Koutsky","year":"1992","unstructured":"Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327(18):1272\u20131278. doi: 10.1056\/NEJM199210293271804","journal-title":"N Engl J Med"},{"issue":"3","key":"1092_CR8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0002-9378(69)90268-3","volume":"105","author":"RM Richart","year":"1969","unstructured":"Richart RM, Barron BA (1969) A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 105(3):386\u2013393. doi: 0002-9378(69)90268-3","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1092_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ostor","year":"1993","unstructured":"Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186\u2013192","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"1092_CR10","first-page":"160","volume":"69","author":"JD Nash","year":"1987","unstructured":"Nash JD, Burke TW, Hoskins WJ (1987) Biologic course of cervical human papillomavirus infection. Obstet Gynecol 69(2):160\u2013162","journal-title":"Obstet Gynecol"},{"issue":"8501","key":"1092_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(86)92067-2","volume":"2","author":"MJ Campion","year":"1986","unstructured":"Campion MJ, McCance DJ, Cuzick J, Singer A (1986) Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 2(8501):237\u2013240. doi: S0140-6736(86)92067-2","journal-title":"Lancet"},{"issue":"4 Pt 2","key":"1092_CR12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0029-7844(98)00245-2","volume":"92","author":"J Melnikow","year":"1998","unstructured":"Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP (1998) Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92(4 Pt 2):727\u2013735","journal-title":"Obstet Gynecol"},{"issue":"9446","key":"1092_CR13","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","volume":"364","author":"AB Moscicki","year":"2004","unstructured":"Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton KL, Farhat S, Broering JM, Darragh TM (2004) Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 364(9446):1678\u20131683. doi: 10.1016\/S0140-6736(04)17354-6","journal-title":"Lancet"},{"issue":"suppl 3","key":"1092_CR14","first-page":"S3\/42","volume":"24","author":"AB Moscicki","year":"2006","unstructured":"Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006) Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 24(suppl 3):S3\/42\u2013S3\/51. doi: 10.1016\/j.vaccine.2006.06.018","journal-title":"Vaccine"},{"issue":"4","key":"1092_CR15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/513992","volume":"175","author":"M Nakagawa","year":"1997","unstructured":"Nakagawa M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F, Moscicki AB, Palefsky JM (1997) Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis 175(4):927\u2013931","journal-title":"J Infect Dis"},{"issue":"2","key":"1092_CR16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/315706","volume":"182","author":"M Nakagawa","year":"2000","unstructured":"Nakagawa M, Stites DP, Patel S, Farhat S, Scott M, Hills NK, Palefsky JM, Moscicki AB (2000) Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis 182(2):595\u2013598. doi: 10.1086\/315706","journal-title":"J Infect Dis"},{"issue":"2","key":"1092_CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/LGT.0b013e3181c6f01e","volume":"14","author":"M Nakagawa","year":"2010","unstructured":"Nakagawa M, Gupta SK, Coleman HN, Sellers MA, Banken JA, Greenfield WW (2010) A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being studied for abnormal pap smear results. J Low Genit Tract Dis 14(2):124\u2013129. doi: 10.1097\/LGT.0b013e3181c6f01e","journal-title":"J Low Genit Tract Dis"},{"issue":"8","key":"1092_CR18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ijc.22894","volume":"121","author":"JW Molling","year":"2007","unstructured":"Molling JW, de Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, van den Eertwegh AJ, Scheper RJ, von Blomberg ME, Bontkes HJ (2007) CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer 121(8):1749\u20131755. doi: 10.1002\/ijc.22894","journal-title":"Int J Cancer"},{"issue":"29","key":"1092_CR19","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1073\/pnas.0704672104","volume":"104","author":"SH Burg van der","year":"2007","unstructured":"van der Burg SH, Piersma SJ, de Jong A, van der Hulst JM, Kwappenberg KM, van den Hende M, Welters MJ, Van Rood JJ, Fleuren GJ, Melief CJ, Kenter GG, Offringa R (2007) Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci USA 104(29):12087\u201312092. doi: 10.1073\/pnas.0704672104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1092_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM Villiers de","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17\u201327. doi: 10.1016\/j.virol.2004.03.033","journal-title":"Virology"},{"issue":"6","key":"1092_CR21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518\u2013527. doi: 10.1056\/NEJMoa021641","journal-title":"N Engl J Med"},{"issue":"8","key":"1092_CR22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/CDLI.12.8.1003-1005.2005","volume":"12","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa M, Kim KH, Moscicki AB (2005) Patterns of CD8 T-cell epitopes within the human papillomavirus type 16 (HPV 16) E6 protein among young women whose HPV 16 infection has become undetectable. Clin Diagn Lab Immunol 12(8):1003\u20131005. doi: 10.1128\/CDLI.12.8.1003-1005.2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"1092_CR23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1172\/JCI12433","volume":"107","author":"R Kaul","year":"2001","unstructured":"Kaul R, Dong T, Plummer FA, Kimani J, Rostron T, Kiama P, Njagi E, Irungu E, Farah B, Oyugi J, Chakraborty R, MacDonald KS, Bwayo JJ, McMichael A, Rowland-Jones SL (2001) CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 107(10):1303\u20131310. doi: 10.1172\/JCI12433","journal-title":"J Clin Invest"},{"issue":"5","key":"1092_CR24","first-page":"483","volume":"11","author":"AS Kadish","year":"2002","unstructured":"Kadish AS, Timmins P, Wang Y, Ho GY, Burk RD, Ketz J, He W, Romney SL, Johnson A, Angeletti R, Abadi M (2002) Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 11(5):483\u2013488","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1092_CR25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bjc.6602679","volume":"93","author":"JC Steele","year":"2005","unstructured":"Steele JC, Mann CH, Rookes S, Rollason T, Murphy D, Freeth MG, Gallimore PH, Roberts S (2005) T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br J Cancer 93(2):248\u2013259. doi: 10.1038\/sj.bjc.6602679","journal-title":"Br J Cancer"},{"issue":"5","key":"1092_CR26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00262-009-0806-4","volume":"59","author":"CL Trimble","year":"2010","unstructured":"Trimble CL, Peng S, Thoburn C, Kos F, Wu TC (2010) Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2\/3. Cancer Immunol Immunother 59(5):799\u2013803. doi: 10.1007\/s00262-009-0806-4","journal-title":"Cancer Immunol Immunother"},{"key":"1092_CR27","first-page":"9","volume":"6","author":"KH Kim","year":"2006","unstructured":"Kim KH, Dishongh R, Santin AD, Cannon MJ, Bellone S, Nakagawa M (2006) Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52\u201361-specific CD8 T cell clone. Cancer Immun 6:9. doi: 060609","journal-title":"Cancer Immun"},{"issue":"2","key":"1092_CR28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ijc.25361","volume":"128","author":"M Heusinkveld","year":"2011","unstructured":"Heusinkveld M, Welters MJ, van Poelgeest MI, van der Hulst JM, Melief CJ, Fleuren GJ, Kenter GG, van der Burg SH (2011) The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors. Int J Cancer 128(2):379\u2013389. doi: 10.1002\/ijc.25361","journal-title":"Int J Cancer"},{"key":"1092_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","volume":"107","author":"D Mougiakakos","year":"2010","unstructured":"Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC (2010) Regulatory T cells in cancer. Adv Cancer Res 107:57\u2013117. doi: 10.1016\/S0065-230X(10)07003-X","journal-title":"Adv Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-1092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-011-1092-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-1092-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:46:56Z","timestamp":1592808416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-011-1092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s00262-011-1092-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,13]]}}}